(12-057) Impact of Glucagon-Like Peptide-1 and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists on Glycemic Control and Insulin Requirements in Adults with Type 1 Diabetes
Wednesday, December 10, 2025
2:00 PM - 3:00 PM
Location: Bayside A, Level 1
Residency Program: Novant Health Forsyth Medical Center Residency Program Type: PGY1 (Pharmacy) Residency Program Location: North Carolina
